Page last updated: 2024-10-27

flumazenil and Fra(X) Syndrome

flumazenil has been researched along with Fra(X) Syndrome in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
D'Hulst, C1
Heulens, I1
Van der Aa, N1
Goffin, K1
Koole, M1
Porke, K1
Van De Velde, M1
Rooms, L1
Van Paesschen, W1
Van Esch, H1
Van Laere, K1
Kooy, RF1

Trials

1 trial available for flumazenil and Fra(X) Syndrome

ArticleYear
Positron Emission Tomography (PET) Quantification of GABAA Receptors in the Brain of Fragile X Patients.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Adolescent; Adult; Animals; Brain; Female; Flumazenil; Fragile X Syndrome; Humans; Male; Mice; Middl

2015